The correlation between CYP2C19 and PON1 Q192R gene polymorphisms and the clinical efficacy and bleeding risk of clopidogrel in acute coronary syndrome patients after percutaneous coronary intervention

XU Xiao-yu; PENG Wen-xing; JING Huan-yu; LIN Yang

doi:10.3969/j.issn.1672-8157.2019.01.002

Home>Articles>The correlation between CYP2C19 and PON1 Q192R gene polymorphisms and the clinical efficacy and bleeding risk of clopidogrel in acute coronary syndrome patients after percutaneous coronary intervention

DOI: 10.3969/j.issn.1672-8157.2019.01.002

The correlation between CYP2C19 and PON1 Q192R gene polymorphisms and the clinical efficacy and bleeding risk of clopidogrel in acute coronary syndrome patients after percutaneous coronary intervention

XU Xiao-yu

PENG Wen-xing

JING Huan-yu

LIN Yang

Machine-generated Keywords：

Publication Date：2019-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 7-10 )

Chinese Journal of Drug Application and Monitoring

ISTIC

ISSN：1672-8157

Year, Vol.(Issue)：2019,16(1)